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RESEARCH ARTICLE
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ABSTRACT
Objectives: The aim of this study was to investigate the differences between idiopathic sudden sen-
sorineural hearing loss (SSNHL), and acute low-tone sensorineural hearing loss (ALHL) using the results
of a nationwide survey database in Japan and to analyze the variables associated with their clinical fea-
tures and the severity of hearing impairment, treatment, and prognosis.
Methods: Participants were patients registered between April 2014 and March 2016 in a multicenter
epidemiological survey database involving 30 university hospitals and medical centers across Japan.
Statistical analysis was performed to clarify the factors associated with their clinical characteristics and
the severity of hearing impairment, treatment, and prognosis.
Results: Idiopathic SSNHL and ALHL differed significantly in terms of male-to-female ratio, age distribu-
tion, and time from onset to start of treatment. The treatment methods and hearing prognosis also dif-
fered markedly between the two diseases. A majority (92%) of idiopathic SSNHL patients were administered
some type of corticosteroid, while half of the ALHL patients received corticosteroids and a diuretic agent.
Conclusion: The results suggested that idiopathic SSNHL and ALHL belonged to different categories of
inner ear disease.
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Introduction
Sudden-onset sensorineural hearing loss consists of two similar
clinical entities; idiopathic sudden sensorineural hearing loss
(SSNHL) and acute low-tone sensorineural hearing loss (ALHL).
Idiopathic SSNHL is defined as hearing levels for SSNHL of
30dB or more over three consecutive frequencies [1,2].
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However, a proportion of the patients whose initial audio-
grams met these criteria also met the criteria for ALHL (see
Table 1 in [3]). ALHL is characterized by acute onset low-
tone hearing loss often associated with tinnitus, ear fullness,
and/or autophony. A series of reports have suggested that
ALHL is correlated with endolymphatic hydrops or
Meniere’s disease (MD) and the clinical characteristics and
hearing prognosis of ALHL differ from those of idiopathic
SSNHL [4–6]. In this study, to investigate the differences
between these two inner ear diseases, we compared SSNHL
and ALHL from both a clinical and epidemiological perspec-
tive using a multi-center large cohort database involving 21
university hospitals and four medical centers.
Materials and methods
The subjects for this analysis were patients (3419 idiopathic
SSNHL and 931 ALHL) registered in the multicenter data-
base between April 2014 and March 2016. Twenty-one uni-
versity hospitals and four medical centers participated in
this epidemiologic survey. The recorded data included sex,
age, body height, weight, affected side, date of onset, onset
age, pure-tone audiogram, past history, and treatment.
Hearing thresholds were measured at octave intervals
between 125Hz and 8 kHz. Initial and final audiograms
were requested for all patients. All data, including the hear-
ing thresholds in the audiograms, were entered into a com-
puter database. From the audiogram data, the grade of the
initial audiogram and the recovery rate, as defined by the
Ministry of Health and Welfare in Japan [7], were obtained.
In some cases, the clinical data were incomplete, but our
analysis included the available data for each category in such
cases.
Idiopathic SSNHL and ALHL were defined according to
the criteria established by the Sudden Deafness Research
Committee of the Ministry of Health and Welfare, Japan
(2012, 2011) as listed in Tables 1 and 2. Criteria for the
severity of hearing loss in ALHL used in this study are
shown in Table 3.
The study protocol was approved by the Ethics Review
Committee of Nagoya University as well as those of all the
other universities. The data were analyzed using SPSS 24.0
for Windows (SPSS, Chicago, IL, USA). Statistical analysis
was performed using the available data in each category,
using a v2 test and Student’s t-test. The level of significance
was set at p< .05.
Results
Prior to detailed analysis, we performed data cleaning of
both the idiopathic SSNHL and ALHL registered data. As a
result of data cleaning, 67 cases registered as idiopathic
SSNHL were found to fulfill the defined ALHL criteria and
36 cases registered as idiopathic SSNHL fulfilled the prob-
able ALHL criteria. To aid in making a more precise com-
parison, we removed these 103 cases from the idiopathic
SSNHL group in the further analysis.
A comparison of the clinical characteristics in 3316 idio-
pathic SSNHL (male: 1719, female: 1556) and 931 ALHL
(male: 241, female: 523) patients is presented in Table 4.
The age of disease onset in patients with ALHL was signifi-
cantly younger than that for idiopathic SSNHL. The mean
onset age of idiopathic SSNHL was 54.5 years (SD ¼17.0)
whereas the mean onset age of ALHL was 38.0 years (SD
¼18.8).
The proportion of women with ALHL was significantly
higher than that with idiopathic SSNHL. For all participants,
the female:male ratio was 0.91:1 for SSNHL and 2.17:1 for
ALHL. In patients <60 years old, the female:male ratio was
0.89:1 for SSNHL and 2.36:1 for ALHL (Figure 1(A) and (B)).
These data indicated that there is a female predominance in
ALHL (p< .01). The number of bilateral affected cases was
significantly higher among the ALHL cases (p< .05) and the
Table 2. Criteria for diagnosis of acute low-tone sensorineural hearing loss
without vertigo.
Main symptoms
1. Acute or sudden onset of cochlear symptoms including ear fullness, tin-
nitus, and hearing loss
2. Low-tone hearing loss
3. Without vertigo
4. Unknown cause
For reference
1. Audiometric criteria of low-tone hearing loss.
(1) The sum of hearing levels at low frequencies of 0.125, 0.25, and
0.5 kHz is 70 dB or more.
(2) The sum of hearing levels at high frequencies of 2, 4, and 8 kHz is
60 dB or less.
2. Cochlear symptoms may be recurrent.
3. May progress to Meniere's disease.
4. May be accompanied with light dizzy sensation.
5. May be bilateral.
Definite: All of the main symptoms. Audiometric criteria (1) and (2).
Probable: All of the main symptoms. Audiometric criteria (1) and the same
hearing levels at high frequencies of 2, 4, and 8 kHz as the contralateral ear.
These criteria were established by the Research Committee of the Ministry of
Health, Labour and Welfare of Japan in 2011.
Table 3. Criteria for the severity of hearing loss in acute low-tone sensori-
neural hearing loss (ALHL) (the Research Committee of the Ministry of Health
and Welfare for Acute Profound Deafness, 2005).
Grade Criteria
1 The sum of hearing levels at 3 low-tone frequencies <100 dB
2 100 dB The sum of hearing levels at 3 low-tone frequencies <130 dB
3 130 dB< The sum of hearing levels at 3 low-tone frequencies <160 dB
4 The sum of hearing levels at 3 low-tone frequencies 160 dB
Table 1. Criteria for diagnosis of sudden deafness.
Main symptoms
Sudden onset
Sensorineural hearing loss, usually severe
Unknown etiology
For reference
Hearing loss (i.e., hearing loss of 30 dB or more over three consecutive
frequencies)
Sudden onset of hearing loss, but may progressively deteriorate over 72 h
No history of recurrent episodes
Unilateral hearing loss, but may be bilateral at the onset
May be accompanied by tinnitus
May be accompanied by vertigo, nausea, and/or vomiting,
without recurrent episodes
No cranial nerve symptoms other than from cranial nerve VIII
Definite diagnosis: all of the above main symptoms are present
These criteria were established by the Research Committee of the Ministry of
Health, Labour and Welfare of Japan in 2012.
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time from onset to start of treatment was significantly longer
for ALHL (mean: 13.5 days) than for idiopathic SSNHL
(mean: 6.5 days) (p< .01).
The initial and final average hearing thresholds at each
frequency for SSNHL and ALHL are shown in Figure 2(A)
and (B). Both the initial and final average PTA for all fre-
quencies were worse for idiopathic SSNHL than for ALHL.
In idiopathic SSNHL, the final average hearing thresholds
for high tones were relatively poorer than those for low
tones.
Systemic corticosteroids are commonly used to treat
patients with acute sensorineural hearing loss (Kitoh et al.
[8], in this special issue). In idiopathic SSNHL patients, sys-
temic steroids were the primary treatment, with intratym-
panic steroids chosen for salvage and substitute treatment
(Kitoh et al. [8], in this special issue). However, in ALHL
patients, systemic or intratympanic steroids were used in
only 54.1% and diuretic agents were used in 63.8% of
patients. Combined treatment with steroids and diuretic
agents was given in 31.4% of patients and diuretic therapy
alone in 27.9% of patients (Figure 3). The rates of complete
recovery for ALHL patients were 72.0% in the systemic ster-
oid group and 83.1% in the diuretic-only group. However,
41.3% of patients in the systemic steroid group had Grade 3
or 4 ALHL, while only 22.8% of patients in the diuretic-only
group had Grade 3 or 4 ALHL. Most patients were simul-
taneously treated with vitamin B12 and adenosine triphos-
phate. The detailed treatments outcome of SSNHL and
ALHL are described in other papers in this supplement
[8–10].
Table 4. Characteristics of the included patients.
Sudden sensorineural
hearing loss
Acute low-tone hearing
loss
Number Percentage (%) Number Percentage (%)
All patients 3316 931
Sex
Male 1719 52.5 241 31.5
Female 1556 47.5 523 68.5
Affected ear
Right 1504 46.5 352 38.0
Light 1702 52.6 521 56.2
Bilateral 30 0.9 54 5.8
Age
15 80 2.6 159 17.5
16–64 2049 65.5 663 72.9
65 999 31.9 87 9.6
Time from onset to the start of treatment
7 days 2585 82.0 454 70.2
8–14 days 397 12.5 77 11.9
15 days 184 5.6 116 17.9
Symptom
Tinnitus 2378 77.8 414 64.6
p< .05.
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Figure 1. (A) Distribution of the incidence of SSNHL in males and females in each group. (B) Distribution of the incidence of ALHL in males and females in each
group.
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Discussion
The present results showed a clear difference between idio-
pathic SSNHL and ALHL in both clinical and epidemio-
logical terms. Possible etiologies of SSHNL include viral
infection, vascular impairment, autoimmune disease, inner
ear pathology, and central nervous system anomalies,
although the cause in most patients is never identified [11].
On the other hand, ALHL has been hypothesized to be
associated with endolymphatic hydrops on the basis of
electrophysiological and audiological characteristics [4–6].
Yamasoba et al. [4] reported that ALHL patients frequently
present with abnormal results for functional tests, such as
the glycerol test or electrocochleography, and that over the
long term, some patients develop cochlear or classic MD.
Some reports have suggested similar clinical features or
abnormal functional test results in ALHL patients and that
ALHL may be caused by endolymphatic hydrops confined
to the cochlea [6]. Recent studies using magnetic resonance
imaging have demonstrated that some patients with ALHL
have evidence of endolymphatic hydrops [3].
The incidence of idiopathic SSNHL was highest in older
men, and that of ALHL was highest in younger women.
These observations supported the view that some idiopathic
SSNHL may be related to vascular disease, particularly as
the rate of cardiovascular events increases with age [12].
Our study showed a significant female predominance in
ALHL patients, which is in agreement with the results of a
previous study [7]. The question of gender difference has
Figure 2. (A) Average of initial and final pure tone audiograms for SSNHL patients. Initial average pure tone audiogram: solid line; final average pure tone audio-
gram: dotted line. (B) Average of initial and final pure tone audiograms for ALHL patients. Initial average pure tone audiogram: solid line; final average pure tone
audiogram: dotted line.
%0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0
Others
IT
SS + IT (salvage)
SS + IT (initial treatment)
Diuretics
SS + diuretics
SS
SD
ALHL
Figure 3. Comparison of the treatment modalities for SSNHL and ALHL. SS: systemic steroids; IT: intratympanic steroids; diuretics: diuretic agent.
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been discussed for MD patients [13], and a hormonal influ-
ence on MD has been suggested. In epidemiological studies,
the gender difference in ALHL appears similar to that for
MD. Nakashima et al. [2] reported that among patients
under 60 years of age, idiopathic SSNHL was more frequent
in women than in men. This tendency was associated with
the incidence of confirmed ALHL in young women. This
must be viewed with some caution, however, as their study
included only idiopathic SSNHL patients who visited private
clinics. Therefore, there may be a certain sampling bias; i.e.,
this population might comprise mild cases and/or those
associated with endolymphatic hydrops or MD.
We analyzed hearing recovery after treatment for idio-
pathic SSNHL [7]. The average hearing level of idiopathic
SSNHL patients was Grade 3 to Grade 2, according to these
criteria, and it was found to improve by about 23 dB (slight
improvement). In our study, idiopathic SSNHL had a poor
hearing prognosis compared to that for ALHL, as shown in
Figure 2(A) and (B).
Diverse treatments have been considered for SSNHL
and ALHL. Corticosteroids are a commonly used treatment
for SSNHL in Japan [2,14]. Recently, intratympanic steroid
administration has been used for some cases [15–17]. In
our study, most idiopathic SSNHL patients received sys-
temic steroids as a primary treatment, whereas a combin-
ation of systemic steroids and diuretic agents was mainly
used for ALHL patients. For cases of severe ALHL, sys-
temic steroids alone or a combination of steroids and diur-
etic agents were frequently administered. Despite the fact
that corticosteroids have been used as the general treat-
ment modality for idiopathic SSNHL in Japan [2,14], the
evidence for steroid treatment is controversial with no sig-
nificant difference in hearing prognosis found in compari-
son with other treatments [18–20]. To improve the
treatment of SSNHL, it is important to clarify its patho-
physiology. With regard to ALHL treatment, diuretic agents
have been used in addition to corticosteroids [21] as endo-
lymphatic hydrops is speculated to be an etiology for
ALHL as it is for MD [3,5].
Our large clinical database revealed differences in the
characteristics of patients with idiopathic SSNHL and ALHL;
however, idiopathic SSNHL and ALHL may include various
pathophysiological states. Future physiological and imaging
studies are needed to clarify the pathophysiological condi-
tions responsible for these inner ear diseases.
Conclusions
The etiologies of idiopathic SSNHL and ALHL remain
unclear. However, the present epidemiological survey sug-
gested that there are clear differences between these two
inner ear diseases, and that some ALHL patients should be
treated as early stage MD.
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